Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1).
Fang, C., D'Souza, B., Thompson, C.F., Clifton, M.C., Fairman, J.W., Fulroth, B., Leed, A., McCarren, P., Wang, L., Wang, Y., Feau, C., Kaushik, V.K., Palmer, M., Wei, G., Golub, T.R., Hubbard, B.K., Serrano-Wu, M.H.(2014) ACS Med Chem Lett 5: 1308-1312
- PubMed: 25516789 
- DOI: https://doi.org/10.1021/ml500388q
- Primary Citation of Related Structures:  
4WGI - PubMed Abstract: 
A direct binding screen of 100 000 sp(3)-rich molecules identified a single diastereomer of a macrolactam core that binds specifically to myeloid cell leukemia 1 (MCL1). A comprehensive toolbox of biophysical methods was applied to validate the original hit and subsequent analogues and also established a binding mode competitive with NOXA BH3 peptide. X-ray crystallography of ligand bound to MCL1 reveals a remarkable ligand/protein shape complementarity that diverges from previously disclosed MCL1 inhibitor costructures.
Organizational Affiliation: 
Broad Institute , 415 Main Street, Cambridge, Massachusetts 02142, United States.